⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
U.S. Biodefense Rapid Pathogen Identification and Treatments Market to Reach $12.1 Billion by 2031
globenewswire.com
TMO
DHR
ABT
ILMN
JNJ
BMY
BIO
AGNC
GSK
RIVN
ORGO
QGEN
Highlights to be presented at Novo’s Capital Markets Day 2026
globenewswire.com
NVO
LLY
AZN
GILD
JNJ
ABBV
NVS
SAN
ROG
GSK
AMGN
MRK
REGN
PFE
BMY
Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape
globenewswire.com
ABBV
JNJ
NVS
UCB
PFE
GSK
AMGN
LLY
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course Scheduled for October 19, 2026
globenewswire.com
GSK
Managing Service Providers Including CRO and CMOs Oversight to Comply with ICH GCP R3 Scheduled for October 14–15, 2027
globenewswire.com
GSK
GLP-1 Therapies Market Set for Rapid Growth Through 2034 as Obesity and Diabetes Demand, Drug Innovation, and Expanding Indications Fuel New Business Opportunities
globenewswire.com
NVO
LLY
AZN
SNY
GSK
How New Englanders Can Protect Their Health During Respiratory Virus Season
prnewswire.com
GSK
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
TLRY
TAK
TNDM
NVS
BMY
PFE
INCY
JNJ
AZN
MRK
ABBV
CRSP
SCLX
RIGL
JAZZ
GILD
REGN
AMGN
BIIB
PTGX
EXAS
SNOW
SRPT
VRTX
BNTX
ALKS
RGEN
IMUX
ADPT
ATRC
CRNX
CYTK
DTIL
EXEL
FGEN
GALT
GNTX
GRFS
GSK
HRMY
IDXX
ILMN
INSM
IONS
IRWD
KODK
LAKE
LULU
LYFT
MAR
MDLZ
MELI
MIRM
MNKD
MRNA
MTCH
NBIX
NCLH
NEM
NTRA
NVCR
ODFL
OMER
ORGO
OTEX
PACB
PBYI
PCAR
PEGA
PERI
PETS
PLRX
PMVP
PPC
PRGS
PRTA
PSNL
PTN
PZZA
QGEN
QTRX
RARE
RCEL
RDHL
RLAY
RLGT
RMD
ROST
RRX
RYAAY
RYTM
SAN
SBAC
SBRA
SEIC
SIGA
SIRI
SITE
SLAB
SLGN
SMCI
SMMT
SNPS
SNY
SOFI
SONO
SPCE
SSYS
STNG
STRA
STRL
STX
SWKS
SYK
SYNA
TCOM
TDOC
TECK
TEVA
TFX
TGTX
TIGR
TRMB
TRVG
TTWO
TUSK
TXRH
ULTA
UMC
UNFI
UNH
URBN
UTHR
VEEV
VELO
VERU
VIVO
VKTX
VLRS
VNDA
VRSK
VSAT
VTGN
WDC
WEC
WERN
WGO
WIX
WMB
WST
WTW
WYNN
XOM
XPER
XPO
XRAY
YETI
YRD
YUM
ZBRA
ZLAB
ZYME
Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer
globenewswire.com
JNJ
GSK
GHO Capital appoints Vivid Sehgal as Operating Partner
globenewswire.com
LIVN
GS
BMY
GSK